Global Neurological Disorder Drugs Market Research Report 2017

January 2017 | 100 pages | ID: GA1B306D0CFEN
QYResearch

Abstracts

Notes:

Production, means the output of Neurological Disorder Drugs

Revenue, means the sales value of Neurological Disorder Drugs

This report studies Neurological Disorder Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Novartis AG
• GlaxoSmithKline plc
• Merck & Co.
• Bayer AG
• AstraZeneca
• Boehringer Ingelheim GmbH
• Teva Pharmaceutical Industries Ltd.
• F. Hoffmann-La Roche Ltd.

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Neurological Disorder Drugs in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan

• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Antipsychotic
• Hypnotic & Sedative
• Analgesics
• Anticoagulants
• Others

Split by application, this report focuses on consumption, market share and growth rate of Neurological Disorder Drugs in each application, can be divided into

• Hospital
• Clinic
• Home

Contents

Global Neurological Disorder Drugs Market Research Report 2017

1 NEUROLOGICAL DISORDER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Neurological Disorder Drugs
1.2 Neurological Disorder Drugs Segment by Type
  1.2.1 Global Production Market Share of Neurological Disorder Drugs by Type in 2015
  1.2.2 Antipsychotic
  1.2.3 Hypnotic & Sedative
  1.2.4 Analgesics
  1.2.5 Anticoagulants
  1.2.6 Others
1.3 Neurological Disorder Drugs Segment by Application
  1.3.1 Neurological Disorder Drugs Consumption Market Share by Application in 2015
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Home
1.4 Neurological Disorder Drugs Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Neurological Disorder Drugs (2011-2021)

2 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Neurological Disorder Drugs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Neurological Disorder Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Neurological Disorder Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Neurological Disorder Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Neurological Disorder Drugs Market Competitive Situation and Trends
  2.5.1 Neurological Disorder Drugs Market Concentration Rate
  2.5.2 Neurological Disorder Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL NEUROLOGICAL DISORDER DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Neurological Disorder Drugs Production and Market Share by Region (2011-2016)
3.2 Global Neurological Disorder Drugs Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL NEUROLOGICAL DISORDER DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Neurological Disorder Drugs Consumption by Regions (2011-2016)
4.2 North America Neurological Disorder Drugs Production, Consumption, Export, Import (2011-2016)
4.3 Europe Neurological Disorder Drugs Production, Consumption, Export, Import (2011-2016)
4.4 China Neurological Disorder Drugs Production, Consumption, Export, Import (2011-2016)
4.5 Japan Neurological Disorder Drugs Production, Consumption, Export, Import (2011-2016)
4.6 Southeast Asia Neurological Disorder Drugs Production, Consumption, Export, Import (2011-2016)
4.7 India Neurological Disorder Drugs Production, Consumption, Export, Import (2011-2016)

5 GLOBAL NEUROLOGICAL DISORDER DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Neurological Disorder Drugs Production and Market Share by Type (2011-2016)
5.2 Global Neurological Disorder Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Neurological Disorder Drugs Price by Type (2011-2016)
5.4 Global Neurological Disorder Drugs Production Growth by Type (2011-2016)

6 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Neurological Disorder Drugs Consumption and Market Share by Application (2011-2016)
6.2 Global Neurological Disorder Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL NEUROLOGICAL DISORDER DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Novartis AG
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Neurological Disorder Drugs Product Type, Application and Specification
    7.1.2.1 Antipsychotic
    7.1.2.2 Hypnotic & Sedative
  7.1.3 Novartis AG Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 GlaxoSmithKline plc
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Neurological Disorder Drugs Product Type, Application and Specification
    7.2.2.1 Antipsychotic
    7.2.2.2 Hypnotic & Sedative
  7.2.3 GlaxoSmithKline plc Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Merck & Co.
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Neurological Disorder Drugs Product Type, Application and Specification
    7.3.2.1 Antipsychotic
    7.3.2.2 Hypnotic & Sedative
  7.3.3 Merck & Co. Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Bayer AG
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Neurological Disorder Drugs Product Type, Application and Specification
    7.4.2.1 Antipsychotic
    7.4.2.2 Hypnotic & Sedative
  7.4.3 Bayer AG Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 AstraZeneca
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Neurological Disorder Drugs Product Type, Application and Specification
    7.5.2.1 Antipsychotic
    7.5.2.2 Hypnotic & Sedative
  7.5.3 AstraZeneca Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Boehringer Ingelheim GmbH
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Neurological Disorder Drugs Product Type, Application and Specification
    7.6.2.1 Antipsychotic
    7.6.2.2 Hypnotic & Sedative
  7.6.3 Boehringer Ingelheim GmbH Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Teva Pharmaceutical Industries Ltd.
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Neurological Disorder Drugs Product Type, Application and Specification
    7.7.2.1 Antipsychotic
    7.7.2.2 Hypnotic & Sedative
  7.7.3 Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 F. Hoffmann-La Roche Ltd.
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Neurological Disorder Drugs Product Type, Application and Specification
    7.8.2.1 Antipsychotic
    7.8.2.2 Hypnotic & Sedative
  7.8.3 F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview

8 NEUROLOGICAL DISORDER DRUGS MANUFACTURING COST ANALYSIS

8.1 Neurological Disorder Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Neurological Disorder Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Neurological Disorder Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Neurological Disorder Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET FORECAST (2016-2021)

12.1 Global Neurological Disorder Drugs Production, Revenue and Price Forecast (2016-2021)
  12.1.1 Global Neurological Disorder Drugs Production and Growth Rate Forecast (2016-2021)
  12.1.2 Global Neurological Disorder Drugs Revenue and Growth Rate Forecast (2016-2021)
  12.1.3 Global Neurological Disorder Drugs Price and Trend Forecast (2016-2021)
12.2 Global Neurological Disorder Drugs Production, Consumption, Import and Export Forecast by Regions (2016-2021)
  12.2.1 North America Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast (2016-2021)
  12.2.2 Europe Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast (2016-2021)
  12.2.3 China Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast (2016-2021)
  12.2.4 Japan Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast (2016-2021)
  12.2.5 Southeast Asia Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast (2016-2021)
  12.2.6 India Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast (2016-2021)
12.3 Global Neurological Disorder Drugs Production, Revenue and Price Forecast by Type (2016-2021)
12.4 Global Neurological Disorder Drugs Consumption Forecast by Application (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neurological Disorder Drugs
Figure Global Production Market Share of Neurological Disorder Drugs by Type in 2015
Figure Product Picture of Antipsychotic
Table Major Manufacturers of Antipsychotic
Figure Product Picture of Hypnotic & Sedative
Table Major Manufacturers of Hypnotic & Sedative
Figure Product Picture of Analgesics
Table Major Manufacturers of Analgesics
Figure Product Picture of Anticoagulants
Table Major Manufacturers of Anticoagulants
Figure Product Picture of Others
Table Major Manufacturers of Others
Table Neurological Disorder Drugs Consumption Market Share by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure Home Examples
Figure North America Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Neurological Disorder Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Neurological Disorder Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Neurological Disorder Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Neurological Disorder Drugs Production Share by Manufacturers
Figure 2016 Neurological Disorder Drugs Production Share by Manufacturers
Table Global Neurological Disorder Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Neurological Disorder Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Neurological Disorder Drugs Revenue Share by Manufacturers
Table 2016 Global Neurological Disorder Drugs Revenue Share by Manufacturers
Table Global Market Neurological Disorder Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Neurological Disorder Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Neurological Disorder Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Neurological Disorder Drugs Product Type
Figure Neurological Disorder Drugs Market Share of Top 3 Manufacturers
Figure Neurological Disorder Drugs Market Share of Top 5 Manufacturers
Table Global Neurological Disorder Drugs Production by Regions (2011-2016)
Figure Global Neurological Disorder Drugs Production and Market Share by Regions (2011-2016)
Figure Global Neurological Disorder Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Neurological Disorder Drugs Production Market Share by Regions
Table Global Neurological Disorder Drugs Revenue by Regions (2011-2016)
Table Global Neurological Disorder Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Neurological Disorder Drugs Revenue Market Share by Regions
Table Global Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table China Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table India Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Neurological Disorder Drugs Consumption Market by Regions (2011-2016)
Table Global Neurological Disorder Drugs Consumption Market Share by Regions (2011-2016)
Figure Global Neurological Disorder Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Neurological Disorder Drugs Consumption Market Share by Regions
Table North America Neurological Disorder Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Neurological Disorder Drugs Production, Consumption, Import & Export (2011-2016)
Table China Neurological Disorder Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Neurological Disorder Drugs Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Neurological Disorder Drugs Production, Consumption, Import & Export (2011-2016)
Table India Neurological Disorder Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Neurological Disorder Drugs Production by Type (2011-2016)
Table Global Neurological Disorder Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Neurological Disorder Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Neurological Disorder Drugs by Type
Table Global Neurological Disorder Drugs Revenue by Type (2011-2016)
Table Global Neurological Disorder Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Neurological Disorder Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Neurological Disorder Drugs by Type
Table Global Neurological Disorder Drugs Price by Type (2011-2016)
Figure Global Neurological Disorder Drugs Production Growth by Type (2011-2016)
Table Global Neurological Disorder Drugs Consumption by Application (2011-2016)
Table Global Neurological Disorder Drugs Consumption Market Share by Application (2011-2016)
Figure Global Neurological Disorder Drugs Consumption Market Share by Application in 2015
Table Global Neurological Disorder Drugs Consumption Growth Rate by Application (2011-2016)
Figure Global Neurological Disorder Drugs Consumption Growth Rate by Application (2011-2016)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Novartis AG Neurological Disorder Drugs Market Share (2015 and 2016)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline plc Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure GlaxoSmithKline plc Neurological Disorder Drugs Market Share (2015 and 2016)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Merck & Co. Neurological Disorder Drugs Market Share (2015 and 2016)
Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer AG Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Bayer AG Neurological Disorder Drugs Market Share (2015 and 2016)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure AstraZeneca Neurological Disorder Drugs Market Share (2015 and 2016)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Boehringer Ingelheim GmbH Neurological Disorder Drugs Market Share (2015 and 2016)
Table Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Market Share (2015 and 2016)
Table F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Market Share (2015 and 2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurological Disorder Drugs
Figure Manufacturing Process Analysis of Neurological Disorder Drugs
Figure Neurological Disorder Drugs Industrial Chain Analysis
Table Raw Materials Sources of Neurological Disorder Drugs Major Manufacturers in 2015
Table Major Buyers of Neurological Disorder Drugs
Table Distributors/Traders List
Figure Global Neurological Disorder Drugs Production and Growth Rate Forecast (2016-2021)
Figure Global Neurological Disorder Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Global Neurological Disorder Drugs Price and Trend Forecast (2016-2021)
Table Global Neurological Disorder Drugs Production Forecast by Regions (2016-2021)
Table Global Neurological Disorder Drugs Consumption Forecast by Regions (2016-2021)
Figure North America Neurological Disorder Drugs Production, Revenue and Growth Rate Forecast (2016-2021)
Table North America Neurological Disorder Drugs Production, Consumption, Export and Import Forecast (2016-2021)
Figure Europe Neurological Disorder Drugs Production, Revenue and Growth Rate Forecast (2016-2021)
Table Europe Neurological Disorder Drugs Production, Consumption, Export and Import Forecast (2016-2021)
Figure China Neurological Disorder Drugs Production, Revenue and Growth Rate Forecast (2016-2021)
Table China Neurological Disorder Drugs Production, Consumption, Export and Import Forecast (2016-2021)
Figure Japan Neurological Disorder Drugs Production, Revenue and Growth Rate Forecast (2016-2021)
Table Japan Neurological Disorder Drugs Production, Consumption, Export and Import Forecast (2016-2021)
Figure Southeast Asia Neurological Disorder Drugs Production, Revenue and Growth Rate Forecast (2016-2021)
Table Southeast Asia Neurological Disorder Drugs Production, Consumption, Export and Import Forecast (2016-2021)
Figure India Neurological Disorder Drugs Production, Revenue and Growth Rate Forecast (2016-2021)
Table India Neurological Disorder Drugs Production, Consumption, Export and Import Forecast (2016-2021)
Table Global Neurological Disorder Drugs Production Forecast by Type (2016-2021)
Table Global Neurological Disorder Drugs Revenue Forecast by Type (2016-2021)
Table Global Neurological Disorder Drugs Price Forecast by Type (2016-2021)
Table Global Neurological Disorder Drugs Consumption Forecast by Application (2016-2021)